- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Submit a Manuscript
- Subscription Information
- Table of Contents
Case Reports in Oncological Medicine
Volume 2012 (2012), Article ID 745292, 5 pages
Nonepiphyseal Giant Cell Tumor of the Rib: A Case Report
1Radiology Department, “Tzaneion” General Hospital, 1 Afentouli and Zanni STR, 18536 Piraeus, Greece
2First Department of Surgery, “Tzaneion” General Hosptial, 1 Afentouli and Zanni STR, 18536 Piraeus, Greece
Received 16 August 2012; Accepted 16 September 2012
Academic Editors: J. De la Garza, M. Romkes, and H. Wang
Copyright © 2012 Hippocrates Moschouris et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
A case of a 32-year-old female patient with a giant cell tumor originating in the middle part of the left 10th rib is presented. On X-rays and CT, the tumor caused a well-defined osteolysis with nonsclerotic borders. On MRI, it exhibited intermediate signal intensity on T1 sequences and central high signal and peripheral intermediate signal on T2 sequences. On contrast-enhanced MR images both central and peripheral-periosteal enhancement was noted. Thanks to its small size ( cm), the lesion was easily resected en bloc with a part of the affected rib. The patient is free of recurrence for 3 years after the operation.
Giant cell tumor (GCT) is a relatively common, benign, locally aggressive tumor that typically presents in the 3rd and 4th decades of life, more commonly affecting women [1–3]. GCT usually affects the ends of the long bones and only rarely the ribs [1–3]. In this paper, we describe the spectrum of imaging findings in case of a GCT with a very unusual rib location. The histopathologic features of the lesion are also presented and our data are correlated with those of the literature.
2. Case Report
A 32-year-old female patient presented with recent onset of left lower chest pain. Her medical history was unremarkable. On the clinical examination, there was a localized tenderness at the middle part of the left tenth rib. She was initially referred for radiographs of the chest and left ribs. A well-circumscribed, ovoid lytic lesion was detected at the middle part of the left tenth rib, causing thinning of the cortex and expansion of the bone (Figure 1). Computed Tomography (CT) confirmed the presence of the lesion, which showed soft tissue density (Figure 2). On Magnetic Resonance Imaging (MRI), the lesion showed intermediate signal intensity on T1 sequences, while on T2 sequences a high signal center and an intermediate signal periphery were observed. After administration of paramagnetic contrast agent, both central and peripheral-periosteal enhancement was noted (Figure 3). Laboratory tests (including serum calcium, phosphorus, acid phosphatase, and alkaline phosphatase) were unremarkable. The tumor was resected en bloc with a small (4.5 cm long) part of the involved rib. No reconstruction of the chest wall with synthetic or autologous material was required. Pathologic examination confirmed the complete resection of the lesion, which measured 2 × 1.3 cm and a diagnosis of giant cell tumor of bone was obtained (Figure 4). Followup was performed with CT (Figure 5), MRI, and laboratory tests. She is free of recurrence for 3 years after the operation.
Giant cell tumors are benign, though aggressive, neoplasms, accounting for 5 to 9 percent of all primary bony tumors . Giant cell tumors are usually found in the long bones, most often the distal femur, proximal tibia, and distal radius . GCT rarely arises in ribs (<1% in most series) [1, 2]. The posterior parts of the rib (head and tubercle) are most commonly affected, while involvement of the nonepiphyseal portions is very rare. Relatively, few case reports have been published with involvement of the anterior or middle part of the rib by GCT [4–8]. The studied tumors were generally large, with exophytic soft tissue component, causing a palpable lump or compressing and displacing adjacent organs (lung, liver, and breast).
On radiographs, GCT of the rib presents as a lytic lesion that may be eccentric and has well-defined, nonsclerotic margins. The lesion causes cortical thinning or even breakthrough and bone expansion . CT clearly demonstrates the osseous lysis caused by the tumor. Matrix calcification is rare. Nevertheless, peripheral calcifications, internal septa (which can also be calcified), and cystic components have been described [4–7]. Disruption of the cortex and extension in the soft tissues can also be appreciated. MRI accurately delineates the tumor, demonstrates the involvement of the adjacent structures, and is helpful for the surgical planning. On the other hand, the MR features of GCT are not specific. Signal intensity is usually low or intermediate on T1W sequences and high on T2W sequences . Inhomogeneous appearance is common, with signal voids (due to calcifications, hemosiderin, or vascular channels) and intensities indicative of hemorrhage at various stages [4, 7, 9]. Fluid-fluid levels are less common than in aneurysmal bone cyst . The number of GCTs of the ribs imaged with MRI is limited. Most of them are larger lesions (compared to the herein presented tumor) with a more inhomogeneous appearance due to degeneration and haemorrhage. On bone scintigraphy, GCT is usually associated with markedly increased radionuclide activity and with a diffuse or “doughnut” pattern. These findings cannot facilitate either detection or characterization of GCT . On FDG-PET, and contrary to the majority of benign bone tumors, GCT is associated with a high standardized uptake value (SUV), which does not differ significantly from the corresponding value of osteosarcoma . Considerations regarding the radiologic differential diagnosis of the lesion of our paper are summarized in Table 1.
Serum acid phosphatase has been found to be increased in many cases of GCTs. It was therefore suggested that serum acid phosphatase could be used as a “tumor marker” for GCT and for monitoring treatment response and disease recurrence. It was also demonstrated that the level of this enzyme is correlated with the size of GCT . In our case, serum acid phosphatase was normal preoperatively (probably due to the small size of the tumor) and remained at the same level postoperatively and during followup.
The remarkable features in our case of GCT are (a) the unusual location of the lesion at the middle part of the rib and (b) the small size of the lesion (in contrast to the majority of the other reported cases), permitting an easy and complete resection with no deformity of the chest wall postoperatively. Despite the multimodality imaging approach, the findings in this case of GCT were atypical and could not establish a preoperative diagnosis. Although remote, the possibility of a giant cell tumor may be included in the differential diagnosis when a relatively small, well-defined lytic lesion of a rib is encountered, even when this lesion is not located at the posterior part of the rib.
Conflict of Interests
All authors declare that they do not have any financial or other competing interests.
All authors had substantial contributions to conception and design, acquisition of data, or analysis and interpretation of data; H. Moschouris and A. Marinis equally contributed in drafting the paper and revised it critically for important intellectual content; all authors gave final approval of the version to be published.
The authors wish to thank Dr. Ch. Glava (Pathology Department, “Tzaneion” Hospital) for her assistance in the study and description of the microscopic image.
- D. C. Dahlin, “Giant cell tumor of bone: highlights of 407 cases,” American Journal of Roentgenology, vol. 144, no. 5, pp. 955–960, 1985.
- H. W. Sung, D. P. Kuo, and W. P. Shu, “Giant-cell tumor of bone: analysis of two hundred and eight cases in Chinese patients,” Journal of Bone and Joint Surgery A, vol. 64, no. 5, pp. 755–761, 1982.
- F. A. Burgener and M. Kormano, Differential Diagnosis in Conventional Radiology, Thieme Medical Publishers, New York, NY, USA, 2nd edition, 1991.
- A. Briccoli, C. Malaguti, C. Iannetti, M. Rocca, and F. Bertoni, “Giant cell tumor of the rib,” Skeletal Radiology, vol. 32, no. 2, pp. 107–110, 2003.
- A. Kumar, M. K. Varshney, V. Trikha, and S. Rastogi, “An unusual presentation of a rare chest wall tumour: giant cell tumour of bone,” Joint Bone Spine, vol. 74, no. 1, pp. 100–102, 2007.
- V. Gupta and R. Mittal, “Giant cell tumor of rib—rare location on the anterior aspect,” Archives of Orthopaedic and Trauma Surgery, vol. 120, no. 3-4, pp. 231–232, 2000.
- R. H. V. Reddy, S. Queen, A. N. A. Jilaihawi, and D. Prakash, “Giant-cell tumour of the rib,” European Journal of Cardio-thoracic Surgery, vol. 24, no. 3, p. 450, 2003.
- J. S. Shin, I. S. Lee, A. Kim, and B. H. Kim, “Giant cell tumor originating from the anterior arc of the rib,” Journal of Korean Medical Science, vol. 17, no. 6, pp. 849–851, 2002.
- U. Tateishi, G. W. Gladish, M. Kusumoto et al., “Chest wall tumors: radiologic findings and pathologic correlation: part 1. Benign tumors,” Radiographics, vol. 23, no. 6, pp. 1477–1490, 2003.
- D. Van Nostrand, J. E. Madewell, and L. M. McNiesh, “Radionuclide bone scanning in giant cell tumor,” Journal of Nuclear Medicine, vol. 27, no. 3, pp. 329–338, 1986.
- J. Aoki, H. Watanabe, T. Shinozaki et al., “FDG PET of primary benign and malignant bone tumors: standardized uptake value in 52 lesions,” Radiology, vol. 219, no. 3, pp. 774–777, 2001.
- S. Ehara, T. Nakayama, J. Nishida, H. Shiraishi, H. Yoshioka, and J. Aoki, “Bone scintigraphic and CT evaluation of chondrosarcoma of the rib: correlation with histological grade in 6 cases,” Annals of Nuclear Medicine, vol. 18, no. 7, pp. 633–636, 2004.
- T. Bartalena, E. Rimondi, G. Rossi, G. Bianchi, and M. Alberghini, “Low grade central chondrosarcoma of the fifth costotransverse joint,” Australasian Radiology, vol. 51, no. 1, pp. B122–B125, 2007.
- T. Akahane, K. Isobe, and T. Shimizu, “Serum total acid phosphatase for monitoring the clinical course of giant cell tumors of bone—26 Patients with 5 local recurrences,” Acta Orthopaedica, vol. 76, no. 5, pp. 651–653, 2005.